Nanotechnology-Based Drug Delivery for Parkinson’s Disease: A Review On Strategies, Efficacy and Translational Hurdles

Meghas Hari, Abhirami Subramony, Deepak Dwivedi, Reshmi S Krishnan, Aswin Damodaran, Sreeja C Nair

Open source

DOI
10.34172/apb.46162
Published
2026-05-09
Container
Advanced Pharmaceutical Bulletin
Publisher
Maad Rayan Publishing Company
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.34172/apb.46162,
  title = {Nanotechnology-Based Drug Delivery for Parkinson’s Disease: A Review On Strategies, Efficacy and Translational Hurdles},
  author = {Meghas Hari and Abhirami Subramony and Deepak Dwivedi and Reshmi S Krishnan and Aswin Damodaran and Sreeja C Nair},
  year = {2026},
  journal = {Advanced Pharmaceutical Bulletin},
  doi = {10.34172/apb.46162},
  url = {https://doi.org/10.34172/apb.46162}
}

RIS

TY  - JOUR
TI  - Nanotechnology-Based Drug Delivery for Parkinson’s Disease: A Review On Strategies, Efficacy and Translational Hurdles
AU  - Meghas Hari
AU  - Abhirami Subramony
AU  - Deepak Dwivedi
AU  - Reshmi S Krishnan
AU  - Aswin Damodaran
AU  - Sreeja C Nair
PY  - 2026
JO  - Advanced Pharmaceutical Bulletin
DO  - 10.34172/apb.46162
UR  - https://doi.org/10.34172/apb.46162
ER  - 

APA

Hari, M., Subramony, A., Dwivedi, D., Krishnan, R. S., Damodaran, A., & Nair, S. C. (2026). Nanotechnology-Based Drug Delivery for Parkinson’s Disease: A Review On Strategies, Efficacy and Translational Hurdles. Advanced Pharmaceutical Bulletin. https://doi.org/10.34172/apb.46162

Source records